Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000936392-06-000211
Filing Date
2006-03-15
Accepted
2006-03-15 16:23:35
Documents
9
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a18400e10vk.htm 10-K 744102
2 EXHIBIT 10.40 a18400exv10w40.htm EX-10.40 10797
3 EXHIBIT 23.1 a18400exv23w1.htm EX-23.1 2490
4 EXHIBIT 31.1 a18400exv31w1.htm EX-31.1 8045
5 EXHIBIT 31.2 a18400exv31w2.htm EX-31.2 7744
6 EXHIBIT 32 a18400exv32.htm EX-32 4534
7 GRAPHIC a18400a1840004.gif GRAPHIC 92540
8 GRAPHIC a18400a1840005.gif GRAPHIC 109189
9 GRAPHIC a18400a1840007.gif GRAPHIC 17141
  Complete submission text file 0000936392-06-000211.txt   1081051
Mailing Address 3115 MERRYFIELD ROW SAN DIEGO CA 92121
Business Address 3115 MERRYFIELD ROW SAN DIEGO CA 92121 8585303600
ANADYS PHARMACEUTICALS INC (Filer) CIK: 0001128495 (see all company filings)

EIN.: 223193172
Type: 10-K | Act: 34 | File No.: 000-50632 | Film No.: 06688543
SIC: 2834 Pharmaceutical Preparations